In the News
In the News
AOTI to Exhibit at 5th Joint Meeting of the European Tissue Repair Society and Wound Healing Society
Galway, Ireland, Sept. 5, 2009 - AOTI Ltd. announced today that it will showcase its revolutionary wound care products at the upcoming ETRS/ WHS meeting in Limoges, France, Sept 25-29. “The Joint Meeting of the ETRS and WHS provides AOTI an ideal venue to demonstrate...
AOTI to Exhibit at European Respiratory Society
Galway, Ireland, Sept. 5, 2009 - AOTI Ltd. announced today that it will showcase its products at the upcoming European Respiratory Society meeting in Vienna, Austria Sept 12-16. “The ERS is the pre-eminent respiratory show in Europe and provides AOTI an ideal venue...
AOTI to Exhibit at 5th Joint Meeting of the European Tissue Repair Society and Wound Healing Society
Galway, Ireland, Sept. 5, 2009 - AOTI Ltd. announced today that it will showcase its revolutionary wound care products at the upcoming ETRS/ WHS meeting in Bled, Slovenia, Sept 25-29. "The Joint Meeting of the ETRS and WHS provides AOTI an ideal venue to demonstrate...
AOTI awarded Federal Supply Schedule (FSS) contract, allowing for Reimbursement of it’s Topical Wound Oxygen therapy within the Veterans Administration (VA) health system and Indian Health Service (IHS)
Galway, Ireland, Sept. 1, 2009 - AOTI Ltd. announced today that it has been awarded a new contract by the General Services Administration (GSA). AOTI’s Federal Supply Schedule (FSS) contract number is V797P-4209b and the initial contract period is for 5 years. “We are...
AOTI adds Director of Sales for Germany
Galway, Ireland, Sept. 1, 2009 - AOTI Ltd. announced today that Tom Hauffe has joined the company as Director of Sales for Germany and German speaking countries. Tom started his career in the medical field as a medical Sergeant in the German Air Force. After leaving...
Ark and AOTI sign international medical device sales collaboration on Kerraboot
London 17 June 2009 - Ark Therapeutics Group Plc ("Ark" or "the Company") announces today that it has signed an agreement with the privately owned global woundcare company, AOTI Ltd. (AOTI), for the supply of Kerraboot in conjunction with AOTI's new Topical Wound...
Clinical Study Validates TWO2 Therapy Effectiveness
Galway, Ireland, May 26- AOTI announced today that a new clinical study published in the May issue of European Journal of Vascular and Endovascular Surgery demonstrates superior wound closure rates for patients suffering from refractory venous ulcers treated with its...
AOTI adds Global Medical Director
Galway, Ireland, May 5- AOTI, INC., announced today that Dr. Christian Frye has joined the company as its Global Medical Director and Chief Science Officer. Christian graduated from the University of Cologne, Germany in 1994 with his Medical Degree and has more than...
AOTI releases enhanced Sacral Therapy Unit
Galway, Ireland, April 15- AOTI announced today the release of its new enhanced multi-size Single Patient Use Sacral Units. “AOTI continues to listen to our customers and make enhancements to our products”, stated Mike Griffiths President and CEO, “our new multi-size...